Saint Lucia

Reimbursed Care Access

Saint Lucia maintains a full statutory control framework for psychoactive substances under its Drugs (Prevention of Misuse) Act; classic serotonergic psychedelics (psilocybin, DMT, mescaline, etc.), ibogaine, and novel phenethylamines (2C‑class) are treated as controlled substances with no routine medical/reimbursed access outside approved clinical research. Ketamine is available and used in medical practice as an anaesthetic and emergency medicine but psychedelic uses are off‑label and not publicly reimbursed; esketamine (Spravato) has no publicly available evidence of a national reimbursement program in Saint Lucia.